Discover Echo – Acquired by Cellink for $110 million in 2021 (5x multiple)Arash Sani2021-09-12T09:33:13-08:00
Trius Therapeutics (formerly Rx3 Pharmaceuticals) – IPO in 2010 – Acquired by Cubic Pharmaceuticals for $704 million in 2013 (3x multiple)John Harbison2021-09-12T08:40:17-08:00
SeQual Technologies – Acquired by Caire (Chart Industries) for $60 million in 2010 (1.3x multiple)John Harbison2021-09-12T08:51:07-08:00
N Spine – Acquired by Synthes for $45 million in 2007 (5x multiple)John Harbison2021-09-12T09:19:09-08:00
Molecular Medicine BioServices – Acquired by Sigma-Aldrich in 2007 (2.6x multiple)John Harbison2021-09-12T09:08:21-08:00
Doctible – Acquired by PracticeTek in 2021 (8x multiple plus equity)John Harbison2022-03-02T20:20:41-08:00
Kalyra Pharmaceuticals – Spun-off Zentalis Pharmaceuticals which IPO’d in 2020 (8x multiple)Arash Sani2021-09-12T08:23:19-08:00
Savara Pharmaceuticals (listed on NASDAQ as SVRA after merger with MAST (3x multiple)Arash Sani2021-09-12T08:09:51-08:00
RetroSense Therapeutics – Acquired by Allergen for $60 million in 2016 (6x multiple)Arash Sani2021-09-12T08:01:46-08:00
InnoZen – Reverse merger with HealthSport Inc. in 2007 (1.5x multiple)Arash Sani2021-09-12T09:05:07-08:00
CRISI Medical Systems – Acquired by Becton Dickinson in 2015 (1.6x multiple)Arash Sani2021-09-12T07:57:52-08:00